To identify relevant signaling proteins downstream of M1R activation, we used selective inhibitors for several kinases whose actions were previously implicated in post-muscarinic receptor signaling in colon cancer; we had previously validated the actions of these inhibitors in human colon cancer cells [23]. The gene discussed is CHRM1; the disease is colonic neoplasm.